Cubist Systematic Strategies’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $150K | Buy |
|
|||||
|
2025
Q1 | $6.36K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $3.37M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $411K | Buy |
|
|||||
|
2023
Q1 | $14.4K | Sell |
|
|||||
|
2022
Q4 | $34.8K | Sell |
|
|||||
|
2022
Q3 | $55K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $23K | Sell |
|
|||||
|
2021
Q4 | $263K | Buy |
|
|||||
|
2021
Q3 | $215K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $76K | Sell |
|
|||||
|
2020
Q4 | $154K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $129K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $116K | Buy |
|
|||||
|
2018
Q4 | $71K | Sell |
|
|||||
|
2018
Q3 | $185K | Sell |
|
|||||
|
2018
Q2 | $341K | Buy |
|
|||||
|
2018
Q1 | $223K | Buy |
|
|||||
|
2017
Q4 | $212K | Buy |
|
|||||
|
2017
Q3 | $149K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $202K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $312K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $111K | Sell |
|
|||||
|
2015
Q1 | $93K | Sell |
|
|||||
|
2014
Q4 | $183K | Buy |
|